Radiologia Brasileira - Publicação Científica Oficial do Colégio Brasileiro de Radiologia

INTRODUCTION

Gadolinium-based hepatocyte-specific contrast agents (HSCAs) allow the functional and anatomical assessment of the biliary tract, thus facilitating the planning of hepatobiliary surgery and the diagnosis of any associated postoperative complications^(1–6). Hepatobiliary surgery involves procedures of great technical difficulty. In many cases, complications related to the biliary tract occur and can be accompanied by unexpected anatomical variations. In liver transplantation, the rate of such complications ranges from 10% to 25%, fatal complications occurring in up to 10% of cases⁽⁷⁾.

Conventional T2-weighted magnetic resonance cholangiography (MRC) has the disadvantage of assessing only the anatomy of the biliary tract, providing little information in cases in which there is no dilatation. Therefore, some studies suggest that a thorough evaluation of the biliary system involves a combination of anatomical and functional evaluation techniques⁽⁸⁾.

The HSCAs approved for clinical use in Brazil⁽⁹⁾, unlike the contrast agents routinely used in magnetic resonance imaging, are selectively captured by functioning hepatocytes and have high rates of elimination (of approximately 50%) through the biliary tract^(1–5,9). The MRC examination protocols should be adapted for time optimization, because it is necessary to obtain late images at 20–30 min after injection of the HSCA^{(5,6,10–12)}.

The aim of the present study was to demonstrate the use of HSCA-enhanced MRC in the perioperative evaluation of the bile ducts. We highlight the main imaging aspects that can inform the practice.


METHODS

We selected MRC examinations in which the HSCA gadoxetic acid (Primovist^®) was used for the perioperative assessment of the upper abdomen in patients undergoing hepatobiliary surgery between January 2013 and February 2015. The images were obtained from the digital archives of our institution.


EVALUATION OF THE BILIARY ANATOMY

Anatomical variations of the biliary tract occur in approximately 30% of individuals. The correct characterization of such variations is necessary in order to avoid iatrogenic injuries during hepatobiliary surgery and procedures, especially in cases of living donors for liver transplantation (Figure 1), in which accurate knowledge of the biliary anatomy is essential^(2,4–6,13).




Delineation of the biliary tree occurs in the late hepatobiliary phase of acquisition, at 20–30 min after HSCA administration. The MRC sequences acquired with HSCA are T1-weighted, providing images with better spatial resolution than those obtained in the T2-weighted sequences employed in conventional (non-contrast-enhanced MRC, especially when there is no dilatation of the bile ducts^{(5,6,10–12)}, as illustrated in Figure 2.




DIFFERENTIATION BETWEEN BILIARY AND NONBILIARY LESIONS

Making a distinction between cystic lesions near the biliary tree and those actually within the biliary tract is important in clinical management. The presence of the HSCA within the lumen of a cystic lesion confirms its biliary origin (Figure 3) and allows the differentiation among choledochal cysts, pericholedochal cystic formations, diverticula, and duodenal duplications^(4,5,11).




DIAGNOSIS OF ACUTE CHOLECYSTITIS

Acute cholecystitis is a common cause of acute abdomen and is initially investigated by ultrasound. However, when the ultrasound findings are inconclusive, HSCA-enhanced MRC can be useful, replacing scintigraphy with diisopropyl iminodiacetic acid (DISIDA scintigraphy). A lack of HSCA uptake in the gallbladder during MRC constitutes a specific sign of acute cholecystitis (similar to that seen in DISIDA scintigraphy), with the additional advantage of allowing evaluation of the differential diagnoses of abdominal pain^{(4–6,11,13,14)}. It is noteworthy that the functional evaluation is considered in combination with the other usual MRC aspects, such as choledocholithiasis (Figure 4), perfusion disorder (Figure 5), gallbladder thickening, and peribiliary fluid collections^(2–4,6,8).




DIAGNOSIS AND GRADING OF BILIARY OBSTRUCTIONS

Changes in the HSCA dynamics in the biliary tract allow the early diagnosis of obstruction, even without evident dilatation (Figure 6), as well as allowing its classification^{(2,4,6,10–14)}, as follows: complete biliary obstruction—absence of contrast uptake in the distal and proximal portions of a stricture or obstructive lesion (Figure 7); nearly complete biliary obstruction—contrast uptake that is significantly late and only in the proximal portion of a stricture or obstructive lesion; or partial biliary obstruction—contrast uptake only outside the area of the stricture or obstructive lesion. Caution should be exercised when evaluating patients with markedly impaired hepatic function, because the dysfunction changes the way in which the HSCA is metabolized, reducing its uptake in the biliary tract and simulating obstructive processes^(6,10,12). Early, accurate grading and characterization of biliary obstructions is important in order to guide the therapeutic practice and, occasionally, the surgical planning^{(2,4,6,10–14)}.




POSTOPERATIVE EVALUATION OF THE BILIARY TRACT

Iatrogenic injuries are the most common complications associated with hepatobiliary surgery, especially performed by laparoscopy. The most common iatrogenic injuries are fistulas, which can occur in the immediate or early postoperative period, and strictures, which occur later^(4–6,11).

The use of HSCA-enhanced MRC allows the diagnosis of extravasations through their direct visualization, as well as demonstrating their origin (Figure 8). Bile duct injury is graded according to the classification system devised by Bismuth, as well as that subsequently devised by Strasberg^(4–6,11).




The combination of conventional (T2-weighted) MRC and HSCA-enhanced MRC has a reported accuracy of 84% for the detection of biliary fistulas⁽⁸⁾. Therefore, the combined use of those two techniques increases the likelihood of the correct identification and localization of the extravasation site (Figure 9)^(4–6,11).




DIFFERENTIAL DIAGNOSIS BETWEEN ABDOMINAL COLLECTIONS AND BILIARY FISTULAS (BILOMAS)

Bilomas are collections of bile outside of the biliary tree. They can be spontaneous, traumatic, or iatrogenic, the majority (70%) occurring in the upper right quadrant of the abdomen. The accurate characterization of a biloma allows it to be distinguished from collections of other natures, as well as informing decisions regarding its management. A late image after HSCA administration confirms that the collection is composed of bile and allows the site of extravasation to be identified^(4,5,11). The use of MRC with a contrast agent that is specific for biliary content allows better differentiation among abdominal collections, loculated ascites, and cystic formations adjacent to the bile ducts (Figure 10), providing important additional information in relation to conventional T2-weighted MRC^(4,5,11).




CONCLUSION

The use of HSCA-enhanced MRC is an important tool that adds functional information in the perioperative assessment of the biliary tree and is complementary to T2-weighted MRC^(3–6). The correct indication and interpretation of the images can alter the clinical practice, as well as precluding the need for other diagnostic tests, invasive procedures, biopsies, or additional interventions^(2,11,12).


REFERENCES

1. Guglielmo FF, Mitchell DG, Gupta S. Gadolinium contrast agent selection and optimal use for body MR imaging. Radiol Clin North Am. 2014;52:637–56.

2. Van Beers BE, Pastor CM, Hussain HK. Primovist, Eovist: what to expect? J Hepatol. 2012;57:421–9.

3. Ringe KI, Husarik DB, Gupta RT, et al. Hepatobiliary transit times of gadoxetate disodium (Primovist®) for protocol optimization of comprehensive MR imaging of the biliary system—what is normal? Eur J Radiol. 2011;79:201–5.

4. Gupta RT. Evaluation of the biliary tree and gallbladder with hepatocellular MR contrast agents. Curr Probl Diagn Radiol. 2013; 42:67–76.

5. Gupta RT, Brady CM, Lotz J, et al. Dynamic MR imaging of the biliary system using hepatocyte-specific contrast agents. AJR Am J Roentgenol. 2010;195:405–13.

6. Seale MK, Catalano O, Saini S, et al. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics. 2009;29:1725–48.

7. Hyodo T, Kumano S, Kushihata F, et al. CT and MR cholangiography: advantages and pitfalls in perioperative evaluation of biliary tree. Br J Radiol. 2012;85:887–96.

8. Kantarci M, Pirimoglu B, Karabulut N, et al. Non-invasive detection of biliary leaks using Gd-EOB-DTPA-enhanced MR cholangiography: comparison with T2-weighted MR cholangiography. Eur Radiol. 2013;23:2713–22.

9. Bittencourt LK, Hausmann D, Gasparetto EL, et al. Ressonância magnética do fígado com contraste hepato-específico: experiência clínica inicial no Brasil. Rev Col Bras Cir. 2012;40:237–40.

10. Goodwin MD, Dobson JE, Sirlin CB, et al. Diagnostic challenges
and pitfalls in MR imaging with hepatocyte-specific contrast agents. Radiographics. 2011;31:1547–68.

11. Lee NK, Kim S, Lee JW, et al. Biliary MR imaging with Gd-EOB-DTPA and its clinical applications. Radiographics. 2009;29:1707–24.

12. Reimer P, Schneider G, Schima W. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol. 2004;14:559–78.

13. Lee SW, Cha SH, Chung HH, et al. Functional magnetic resonance cholangiography with Gd-EOB-DTPA: a study in healthy volunteers. Magn Reson Imaging. 2014;32:385–91.

14. Flancbaum L, Choban PS, Sinha R, et al. Morphine cholescintigraphy in the evaluation of hospitalized patients with suspected acute cholecystitis. Ann Surg. 1994;220:25–31.










1. MD, Radiologist, Hospital Sírio-Libanês, São Paulo, SP, Brazil
2. MD, Radiologist, Hospital Sírio-Libanês and Instituto do Câncer do Estado de São Paulo (Icesp), São Paulo, SP, Brazil
3. MD, Radiologist, Hospital Regional de Presidente Prudente and Hospital Nossa Senhora das Graças, Presidente Prudente, SP, Brazil
4. PhD, MD, Radiologist, Hospital Sírio-Libanês and Instituto do Câncer do Estado de São Paulo (Icesp), São Paulo, SP, Brazil
5. Associate Professor in the Department of Radiology and Oncology of the Faculdade de Medicina da Universidade de São Paulo (FMUSP), Radiologist, Hospital Sírio-Libanês, São Paulo, SP, Brazil
6. Full Professor in the Department of Radiology and Oncology of the Faculdade
de Medicina da Universidade de São Paulo (FMUSP), Radiologist, Hospital Sírio-Libanês, São Paulo, SP, Brazil

Study conducted at the Hospital Sírio-Libanês, São Paulo, SP, Brazil.

Mailing address:
Dr. Luciana Carmen Zattar-Ramos
Hospital Sírio-Libanês
Rua Dona Adma Jafet, 91, Bela Vista
São Paulo, SP, Brazil, 01308-050
E-mail: lucianazattar@hotmail.com
Received November 8, 2015.
Accepted after revision June 7, 2016.